@article{384cd594f3044e4693d343bfc8471e4f,
title = "Protein–ligand binding affinity prediction of cyclin-dependent kinase-2 inhibitors by dynamically averaged fragment molecular orbital-based interaction energy",
abstract = "Fragment molecular orbital (FMO) method is a powerful computational tool for structure-based drug design, in which protein–ligand interactions can be described by the inter-fragment interaction energy (IFIE) and its pair interaction energy decomposition analysis (PIEDA). Here, we introduced a dynamically averaged (DA) FMO-based approach in which molecular dynamics simulations were used to generate multiple protein–ligand complex structures for FMO calculations. To assess this approach, we examined the correlation between the experimental binding free energies and DA-IFIEs of six CDK2 inhibitors whose net charges are zero. The correlation between the experimental binding free energies and snapshot IFIEs for X-ray crystal structures was R2 = 0.75. Using the DA-IFIEs, the correlation significantly improved to 0.99. When an additional CDK2 inhibitor with net charge of −1 was added, the DA FMO-based scheme with the dispersion energies still achieved R2 = 0.99, whereas R2 decreased to 0.32 employing all the energy terms of PIEDA.",
keywords = "cyclin-dependent kinase-2 inhibitors, dynamical average, fragment molecular orbital method, inter-fragment interaction energy, pair interaction energy decomposition analysis",
author = "Kenichiro Takaba and Chiduru Watanabe and Atsushi Tokuhisa and Yoshinobu Akinaga and Biao Ma and Ryo Kanada and Mitsugu Araki and Yasushi Okuno and Yusuke Kawashima and Hirotomo Moriwaki and Norihito Kawashita and Teruki Honma and Kaori Fukuzawa and Shigenori Tanaka",
note = "Funding Information: The authors thank Prof. Yuji Mochizuki at Rikkyo University, Dr. Tatsuya Nakano and Dr. Yoshio Okiyama at the National Institute of Health Sciences (NIHS) for general discussions related to FMO calculations, as well as Dr. Daisuke Takaya and Dr. Kikuko Kamisaka at RIKEN for supporting FMODB registration. In particular, we thank Prof. Mochizuki for providing the Oakforest‐PACS version of ABINIT‐MP and many advices on its use on the supercomputers. This research was done in activities of the FMO drug design consortium (FMODD). The results were obtained using the K computer (project ID: hp190119), TSUBAME3.0 (projectID: hp190133), and Oakforest‐PACS (projectID: hp200101). This research was partially supported by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from AMED under Grant Number JP21am0101113 as well as JSPS Kakenhi (JP17H06353, JP18K03825, and JP21K06098) and MEXT Quantum Leap Flagship Program (MEXT QLEAP) Grant Number JPMXS0120330644. Publisher Copyright: {\textcopyright} 2022 Wiley Periodicals LLC.",
year = "2022",
month = jul,
day = "30",
doi = "10.1002/jcc.26940",
language = "English",
volume = "43",
pages = "1362--1371",
journal = "Journal of Computational Chemistry",
issn = "0192-8651",
publisher = "John Wiley and Sons Inc.",
number = "20",
}